"The past year witnessed the US Federal Trade Commission (FTC) and the Department of Justice (DOJ) Antitrust Division making good on promises for vigorous merger enforcement, with a sharp focus on high-tech industries, including the pharmaceutical and technology industries. Garnering significant media attention, antitrust is now mainstream, grabbing headline-worthy statements from all corners of the US government, ranging from President Trump, presidential candidates, members of Congress, state attorneys general, the Food and Drug Association, the Federal Communications Commission and, of course, the FTC and the DOJ."
Read the chapter
An extract from GCR’s Americas Antitrust Review 2020, first published in September 2019. The whole publication is available on Global Competition Review's website.